| Tretinoin | Approved Investigational Nutraceutical | ANXA1 | 301 |
downregulated | Tretinoin results in decreased expression of ANXA1 mRNA | 9q21.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA1 | 301 |
upregulated | Tretinoin results in increased expression of ANXA1 mRNA | 9q21.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA11 | 311 |
upregulated | Tretinoin results in increased expression of ANXA11 mRNA | 10q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA2 | 302 |
downregulated | Tretinoin results in decreased expression of ANXA2 mRNA | 15q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA3 | 306 |
upregulated | Tretinoin results in increased expression of ANXA3 mRNA | 4q21.21 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA4 | 307 |
upregulated | Tretinoin results in increased expression of ANXA4 mRNA | 2p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA5 | 308 |
downregulated | Tretinoin results in decreased expression of ANXA5 mRNA | 4q27 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA5 | 308 |
upregulated | Tretinoin results in increased expression of ANXA5 mRNA | 4q27 | |
| Tretinoin | Approved Investigational Nutraceutical | ANXA8L1 | 728113 |
downregulated | Tretinoin results in decreased expression of ANXA8L1 mRNA | 10q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | AP1G1 | 164 |
upregulated | Tretinoin results in increased expression of AP1G1 mRNA | 16q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | AP1S2 | 8905 |
downregulated | Tretinoin results in decreased expression of AP1S2 mRNA | Xp22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | AP1S2 | 8905 |
upregulated | Tretinoin results in increased expression of AP1S2 mRNA | Xp22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | AP4S1 | 11154 |
downregulated | Tretinoin results in decreased expression of AP4S1 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | AP4S1 | 11154 |
upregulated | Tretinoin results in increased expression of AP4S1 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | AP5Z1 | 9907 |
downregulated | Tretinoin results in decreased expression of AP5Z1 mRNA | 7p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | APBA3 | 9546 |
upregulated | Tretinoin results in increased expression of APBA3 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | APBB2 | 323 |
downregulated | Tretinoin results in decreased expression of APBB2 mRNA | 4p14-p13 | |
| Tretinoin | Approved Investigational Nutraceutical | APC | 324 |
downregulated | Tretinoin results in decreased expression of APC mRNA | 5q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | APC | 324 |
upregulated | Tretinoin results in increased expression of APC mRNA | 5q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | APLP2 | 334 |
upregulated | Tretinoin results in increased expression of APLP2 mRNA | 11q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | APOA2 | 336 |
upregulated | Tretinoin results in increased expression of APOA2 mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | APOD | 347 |
upregulated | Tretinoin results in increased expression of APOD mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | APOE | 348 |
downregulated | Tretinoin results in decreased expression of APOE mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | APOLD1 | 81575 |
upregulated | Tretinoin results in increased expression of APOLD1 mRNA | 12p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AQP10 | 89872 |
downregulated | Tretinoin results in decreased expression of AQP10 mRNA | 1q21.3 | |